Authors: | Mailankody, S.; Salcedo, M.; Tavitian, E.; Burge, M.; Korde, N.; Hassoun, H.; Lesokhin, A.; Lahoud, O.; Smith, E.; Hultcrantz, M.; Tan, C.; Shah, U.; Devlin, S.; Landgren, O. |
Title: | Ixazomib and dexamethasone in high risk smoldering multiple myeloma: A clinical and correlative pilot study |
Keywords: | clinical article; aged; fatigue; follow up; antineoplastic agent; prospective study; letter; progression free survival; multiple myeloma; antineoplastic combined chemotherapy protocols; maintenance therapy; dexamethasone; high risk patient; acute kidney failure; pilot study; pilot projects; urinary tract infection; comorbidity; lung infection; disease exacerbation; boron compounds; overall response rate; combination drug therapy; smoldering multiple myeloma; humans; human; boron derivative; ixazomib |
Journal Title: | Leukemia and Lymphoma |
Volume: | 63 |
Issue: | 11 |
ISSN: | 1042-8194 |
Publisher: | Taylor & Francis Group |
Date Published: | 2022-01-01 |
Start Page: | 2760 |
End Page: | 2761 |
Language: | English |
DOI: | 10.1080/10428194.2022.2095626 |
PUBMED: | 35838493 |
PROVIDER: | scopus |
DOI/URL: | |
Notes: | Letter -- Export Date: 1 December 2022 -- Source: Scopus |